NCT05184777View on ClinicalTrials.gov

Evaluation of Salivary ELISA for Hormone Monitoring in IVF Patients

NACompletedINTERVENTIONAL

Enrollment

120

Participants

Timeline

Start Date

February 3, 2022

Primary Completion Date

May 17, 2022

Study Completion Date

February 20, 2023

Conditions

Infertility, FemaleReproductive Sterility

Interventions

DIAGNOSTIC_TEST

Determination of progesterone and oestradiol

Blood and saliva samples will be taken for determination of progesterone and oestradiol hormones.

Trial Locations (1)

46003

IVI Valencia, Valencia

Sponsors

Collaborators (1)

MINT DIAGNOSTICS

All Listed Sponsors

collaborator

MINT DIAGNOSTICS

UNKNOWN

lead

Instituto Valenciano de Infertilidad, IVI VALENCIA

OTHER